Sciegen Pharmaceuticals recalls

Sciegen Pharmaceuticals has 7 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 8 Mar 2023. The most frequent reason is nitrosamine impurity.

Total recalls7since 2018

Last 12 months0reported

Class I00% of total

Ongoing0latest 8 Mar 2023

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 6 86%Class III 1 14%

Why sciegen pharmaceuticals is recalled

Nitrosamine Impurity686%
Other Reasons114%

Product types

Blood Pressure Medication686%
Pain Medication114%

By year

2023114%
2018686%

All sciegen pharmaceuticals recalls, newest first

7 total

Reported	Class	Recall	Company	Reason	Where
8 Mar 2023Drug	CLASS III	Gabapentin Tablets, USP 600 mg recalled by Sciegen PharmaceuticalsGabapentin	Sciegen Pharmaceuticals	Other	Nationwide
28 Nov 2018Drug	CLASS II	Westminister Irbesartan Tablets, USP, 300mg recalled	Sciegen Pharmaceuticals	Nitrosamine Impurity	Nationwide
28 Nov 2018Drug	CLASS II	GSMS Irbesartan Tablets, USP, 300 mg,(a) bottle recalled	Sciegen Pharmaceuticals	Nitrosamine Impurity	Nationwide
28 Nov 2018Drug	CLASS II	GSMS Irbesartan Tablets, USP, 75 mg recalled by Sciegen Pharmaceuticals	Sciegen Pharmaceuticals	Nitrosamine Impurity	Nationwide
28 Nov 2018Drug	CLASS II	Westminister Irbesartan Tablets, USP, 150 mg, (a) bottle recalled	Sciegen Pharmaceuticals	Nitrosamine Impurity	Nationwide
28 Nov 2018Drug	CLASS II	GSMS Irbesartan Tablets, USP, 150 mg, (a) bottle recalled	Sciegen Pharmaceuticals	Nitrosamine Impurity	Nationwide
28 Nov 2018Drug	CLASS II	Westminister Irbesartan Tablets, USP, 75 mg (a) bottle recalled	Sciegen Pharmaceuticals	Nitrosamine Impurity	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.